OTC Firms Should Improve Monograph Compliance, Registration – CDER
This article was originally published in The Tan Sheet
Executive Summary
CDER recommends the OTC industry ensure product innovations comply with monographs or have FDA approval prior to marketing. Umbrella-branding and facility registration rank high for the drug center in 2013.
You may also be interested in...
Adverse Events Spark FDA Evaluation Of Topical Acne Ingredients
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.
FDA Evaluates Topical Acne Ingredients After Adverse Event Report Jump
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.
FDA Evaluates Topical Acne Ingredients After Adverse Event Report Jump
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.